active: true
branding:
    icon_url: https://api.polygon.io/v1/reference/company-branding/ZHJyZWRkeXMuY29t/images/2025-04-04_icon.jpeg
    logo_url: https://api.polygon.io/v1/reference/company-branding/ZHJyZWRkeXMuY29t/images/2025-04-04_logo.svg
cik: 0001135951
composite_figi: BBG000NJ96L6
currency_name: usd
description: Dr. Reddy's is one of the largest generic drug manufacturers in the world.
    It has a significant presence in North America, a region that makes up roughly
    half of its generics sales, and it services India (about 20% of its generics sales),
    Russia (10%), and certain European and Latin American countries. Beyond simple
    generics, Dr. Reddy's also has a solid portfolio of injectables which make up
    25% of its North America sales. In branded generic markets like India, Dr. Reddy's
    has established a compelling presence with its strong brand name and earned a
    top five spot in key therapeutic areas including oncology and gastroenterology.
    Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures
    over 150 APIs and sells in over 75 countries.
homepage_url: https://www.drreddys.com
list_date: '2001-04-11'
locale: us
market: stocks
market_cap: 11869608321.0
name: Dr. Reddy's Laboratories Limited American Depositary Shares
primary_exchange: XNYS
round_lot: 100
share_class_figi: BBG001SHMCN3
share_class_shares_outstanding: 834898140
ticker: RDY
ticker_root: RDY
total_employees: 27811
type: ADRC
weighted_shares_outstanding: 832370850
